Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice

Secreted frizzled-related protein 4 (SFRP4) is an extracellular regulator of the wingless-type mouse mammary tumor virus integration site family (WNT) pathway. SFRP4 has been implicated in adipocyte dysfunction, obesity, insulin resistance, and impaired insulin secretion in patients with type 2 diab...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology (Philadelphia) Vol. 156; no. 12; pp. 4502 - 4510
Main Authors: Mastaitis, Jason, Eckersdorff, Mark, Min, Soo, Xin, Yurong, Cavino, Katie, Aglione, Johnpaul, Okamoto, Haruka, Na, Erqian, Stitt, Trevor, Dominguez, Melissa G, Schmahl, Jennifer P, Lin, Calvin, Gale, Nicholas W, Valenzuela, David M, Murphy, Andrew J, Yancopoulos, George D, Gromada, Jesper
Format: Journal Article
Language:English
Published: United States Endocrine Society 01-12-2015
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Secreted frizzled-related protein 4 (SFRP4) is an extracellular regulator of the wingless-type mouse mammary tumor virus integration site family (WNT) pathway. SFRP4 has been implicated in adipocyte dysfunction, obesity, insulin resistance, and impaired insulin secretion in patients with type 2 diabetes. However, the exact role of SFRP4 in regulating whole-body metabolism and glucose homeostasis is unknown. We show here that male Sfrp4−/− mice have increased spine length and gain more weight when fed a high-fat diet. The body composition and body mass per spine length of diet-induced obese Sfrp4−/− mice is similar to wild-type littermates, suggesting that the increase in body weight can be accounted for by their longer body size. The diet-induced obese Sfrp4−/− mice have reduced energy expenditure, food intake, and bone mineral density. Sfrp4−/− mice have normal glucose and insulin tolerance and β-cell mass. Diet-induced obese Sfrp4−/− and control mice show similar impairments of glucose tolerance and a 5-fold compensatory expansion of their β-cell mass. In summary, our data suggest that loss of SFRP4 alters body length and bone mineral density as well as energy expenditure and food intake. However, SFRP4 does not control glucose homeostasis and β-cell mass in mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0013-7227
1945-7170
DOI:10.1210/en.2015-1257